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Background:  Little is known about the frequency and long-term outcome of asymptomatic (asx) left ventricular (LV) dysfunction.
methods:  We performed a retrospective analysis of the EHR and echo database within the Geisinger Health System of adults with an 
LVEF <40% on echo or ventriculogram without a prior diagnosis of heart failure (HF) or loop diuretic use between 1/01/00 and 7/01/14. 
Baseline characteristics, medications, frequency and timing of the subsequent development of HF, and survival were analyzed.
results:  We identified 10,662 pts with asx LVEF <40%. The frequency of diagnosis rose from 306/yr to >2000/yr. Their mean age at the 
time of diagnosis was 72; 66% were male, 28% had diabetes, 49% had hypertension, 53% had CAD and 13% had a prior MI. Mean LVEF 
was 30%; mean BMI was 32%. By 6 months after diagnosis, 68% were on an ACEI/ARB and 30% on an evidence-based beta blocker. Of 
these 10,662 asx pts with an LVEF <40%, 37% were diagnosed with HF within the subsequent 6 months; thereafter, the annual frequency 
with which HF was diagnosed was ~5%/year, and 4,959 pts remain free of HF a median of 569 days after the diagnosis (IQR 77, 1268 
days). Kaplan Meier survival (time from diagnosis to death) is revealed in Figure 1.
conclusion:  Asx LV dysfunction is not uncommon. Therapy with an ACEI/ARB and beta blocker is not initiated within 6 months in many 
patients. Many (37%) are diagnosed with HF within 6 months, but the subsequent frequency of development of HF is ~5%/year. Mortality in 
the years after diagnosis is high.
Figure 1
 
